In a single-patient illustrative case, Mine et al., from Kyushu University, Fukuoka, Japan, published in the Journal of Neurosurgery Case Lessons, report the first adult case of Dentatorubral-pallidoluysian atrophy (DRPLA)-associated progressive myoclonic epilepsy (PME) treated with a total corpus callosotomy (CC) for refractory seizures.
→ Outcome: Total CC led to a marked reduction in seizure frequency. Tonic seizures and FBTCSs with desaturation resolved by 1 year, with notable improvement in quality of life (QOL).
🔎 Critical Appraisal
-
🟢 Strengths
-
Novelty: First reported adult DRPLA-PME corpus callosotomy.
-
Clearly disabling epilepsy: Myoclonus, tonic seizures, desaturation.
-
Clear outcome: Sustained seizure reduction at 1-year.
-
-
🟡 Limitations
-
Single case → low external validity.
-
No comparator: No data vs. anterior CC or other therapies.
-
Cognitive effects unquantified.
-
DRPLA is a diffuse neurodegenerative disease; CC does not target focus directly.
-